Cargando…
Interleukin-22 modulates cisplatin sensitivity of osteosarcoma cells by regulating the STAT3 signaling pathway
The present study aimed to investigate the regulatory mechanisms by which interleukin (IL)-22 regulates cisplatin (DDP) sensitivity in osteosarcoma cells. Firstly, reverse transcription-quantitative (RT-q) PCR and western blotting demonstrated that IL-22 expression was significantly increased in ost...
Autores principales: | Li, Zhiqiang, Xu, Renjie, Zhang, Xiangxin, Shen, Jun, Chen, Guangxiang, Zou, Tianming, Yu, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6966104/ https://www.ncbi.nlm.nih.gov/pubmed/32010312 http://dx.doi.org/10.3892/etm.2019.8352 |
Ejemplares similares
-
Interleukin-22 Promotes Osteosarcoma Cell Proliferation and Invasion via STAT3 Activation
por: Li, Panpan, et al.
Publicado: (2018) -
MicroRNA-22 inhibits the proliferation and migration, and increases the cisplatin sensitivity, of osteosarcoma cells
por: Zhou, Xiang, et al.
Publicado: (2018) -
FBXO2 modulates STAT3 signaling to regulate proliferation and tumorigenicity of osteosarcoma cells
por: Zhao, Xunming, et al.
Publicado: (2020) -
MicroRNA-22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma
por: Meng, Chen-Yang, et al.
Publicado: (2020) -
Cordycepin augments the chemosensitivity of osteosarcoma to cisplatin by activating AMPK and suppressing the AKT signaling pathway
por: Li, Hong-Bo, et al.
Publicado: (2021)